Tajuk : The FDA just approved the first new drug to treat ALS in 22 years
link : The FDA just approved the first new drug to treat ALS in 22 years
The FDA just approved the first new drug to treat ALS in 22 years
YouTube/Bill and Melinda Gates Foundation
Melinda Gates participates in the viral ALS ice bucket challenge in 2014.
May 5 (Reuters) -The FDA just approved a new drug to ALS.
It’s the first new drug to get US approval in 22 years.
The drug, known chemically as edaravone, is already sold by Japanese pharmaceutical company Mitsubishi Tanabe Pharma Corp (MTPC) in Japan and South Korea.
The last drug approved to treat ALS was Riluzole in 1995, and it’s used to delay the need for a breathing tube, but isn’t a cure.
After six months of treatment with edaravone on top of standard-of-care, data showed the intravenous drug reduced the rate of functional decline in patients by about a third, Dr Jean Hubble, VP of medical affairs, at MTPC’s U.S. unit MT Pharma America (MTPA), said.
The cause of ALS is largely unknown. It garnered international attention when New York Yankees player Lou Gehrig abruptly retired from baseball in 1939, after being diagnosed with the disease.
In 2014, ALS returned to the spotlight with the “Ice Bucket Challenge,” which involved people pouring ice-cold water over their heads, posting a video on social media, and donating funds for research on the condition, whose sufferers include British physicist Stephen Hawking.
The rare progressive condition attacks nerve cells located in the brain and spinal cord responsible for controlling voluntary muscles.
Eventually, the brain’s ability to start and control voluntary movement is lost, and the patient succumbs to the disease – usually three to five years from the onset of symptoms.
The FDA was expected to make its decision on edaravone by June 16. It’ll be sold under the brand name Radicava, and the drug should be available in the United States by August, MTPA Chief Commercial Officer Tom Larson said.
He declined to disclose edaravone sales data from Japan and South Korea in an interview with Reuters in anticipation of the FDA announcement.
Another promising drug for ALS is being developed by French drugmaker AB Science SA, which in March reported positive late-stage data on its drug, masitinib. The drug is now under European review.
More than 6,000 people in the United States are diagnosed with ALS each year, according to the ALS Association.
Reuters reporting by Natalie Grover.
Read more stories on Business Insider, Malaysian edition of the world’s fastest-growing business and technology news website.
✍ Sumber Pautan : ☕ Business InsiderBusiness Insider
Kredit kepada pemilik laman asal dan sekira berminat untuk meneruskan bacaan sila klik link atau copy paste ke web server : http://ift.tt/2q8Jsvr
(✿◠‿◠)✌ Mukah Pages : Pautan Viral Media Sensasi Tanpa Henti. Memuat-naik beraneka jenis artikel menarik setiap detik tanpa henti dari pelbagai sumber. Selamat membaca dan jangan lupa untuk 👍 Like & 💕 Share di media sosial anda!
YouTube/Bill and Melinda Gates Foundation
Melinda Gates participates in the viral ALS ice bucket challenge in 2014.
May 5 (Reuters) -The FDA just approved a new drug to ALS.
It’s the first new drug to get US approval in 22 years.
The drug, known chemically as edaravone, is already sold by Japanese pharmaceutical company Mitsubishi Tanabe Pharma Corp (MTPC) in Japan and South Korea.
The last drug approved to treat ALS was Riluzole in 1995, and it’s used to delay the need for a breathing tube, but isn’t a cure.
After six months of treatment with edaravone on top of standard-of-care, data showed the intravenous drug reduced the rate of functional decline in patients by about a third, Dr Jean Hubble, VP of medical affairs, at MTPC’s U.S. unit MT Pharma America (MTPA), said.
The cause of ALS is largely unknown. It garnered international attention when New York Yankees player Lou Gehrig abruptly retired from baseball in 1939, after being diagnosed with the disease.
In 2014, ALS returned to the spotlight with the “Ice Bucket Challenge,” which involved people pouring ice-cold water over their heads, posting a video on social media, and donating funds for research on the condition, whose sufferers include British physicist Stephen Hawking.
The rare progressive condition attacks nerve cells located in the brain and spinal cord responsible for controlling voluntary muscles.
Eventually, the brain’s ability to start and control voluntary movement is lost, and the patient succumbs to the disease – usually three to five years from the onset of symptoms.
The FDA was expected to make its decision on edaravone by June 16. It’ll be sold under the brand name Radicava, and the drug should be available in the United States by August, MTPA Chief Commercial Officer Tom
He declined to disclose edaravone sales data from Japan and South Korea in an interview with Reuters in anticipation of the FDA announcement.
Another promising drug for ALS is being developed by French drugmaker AB Science SA, which in March reported positive late-stage data on its drug, masitinib. The drug is now under European review.
More than 6,000 people in the United States are diagnosed with ALS each year, according to the ALS Association.
Reuters reporting by Natalie Grover.
Read more stories on Business Insider, Malaysian edition of the world’s fastest-growing business and technology news website.
✍ Sumber Pautan : ☕ Business InsiderBusiness Insider
Kredit kepada pemilik laman asal dan sekira berminat untuk meneruskan bacaan sila klik link atau copy paste ke web server : http://ift.tt/2q8Jsvr
(✿◠‿◠)✌ Mukah Pages : Pautan Viral Media Sensasi Tanpa Henti. Memuat-naik beraneka jenis artikel menarik setiap detik tanpa henti dari pelbagai sumber. Selamat membaca dan jangan lupa untuk 👍 Like & 💕 Share di media sosial anda!
dengan itu Perkara The FDA just approved the first new drug to treat ALS in 22 years
Kini anda membaca artikel The FDA just approved the first new drug to treat ALS in 22 years dengan alamat pautan https://timesnewmalaysia.blogspot.com/2017/05/the-fda-just-approved-first-new-drug-to.html
Related Posts :
Keluarga Pengantin Usung Duit Rm600,000, Bukti Kekayaan Kepada Bakal Besan.- Guru Ditahan Disyaki Liwat Pelajar
6 penuntut UPNM didakwa bunuh Zulfarhan, berdepan hukuman gantung sampai mati
Perkhidmatan Qatar Airways Berjalan Lancar- Di Tahap Akhir…RUMUSAN KES KEMATIAN PELAJAR UPNM Vol 3: Lima penuntut UPNM dituduh bunuh Zulfarhan..
0 Response to "The FDA just approved the first new drug to treat ALS in 22 years"
Catat Ulasan